30 окт. 2024 г. · U.S. Humira net revenues were $1.765 billion, a decrease of 41.6 percent. Internationally, Humira net revenues were $462 million, a decrease ...

Global Humira net revenues of $2.270 billion decreased 35.9 percent on a reported basis, or 35.2 percent on an operational basis. · Global Skyrizi net revenues ...

29 апр. 2024 г. · AbbVie reported a worldwide net revenue of $12.31 billion in the first quarter of 2024 despite Humira sales dropping due to biosimilar competition.

30 окт. 2024 г. · Arthritis drug Humira's global sales of $2.23 billion in the third quarter missed estimates of $2.39 billion. Its U.S. sales fell 42%, ...

2 дня назад · This statistic depicts the share of adalimumab sales attributable to Humira compared to its biosimilars, as of August 2024.

25 июл. 2024 г. · ... Humira's market share has dropped to 82% since May 2024, down around 13% from March. Meanwhile, the overall biosimilar share has grown to ...

1 мая 2024 г. · Humira revenue plunged more than 30% to $2.3 billion during the first quarter, according to AbbVie. For years, AbbVie has built up a wall of ...

22 февр. 2024 г. · Due to patent loss and biosimilars competition, it is expected that the revenue will decrease to some 13 billon dollars until 2024.

24 окт. 2024 г. · Since its launch in 2003 for rheumatoid arthritis, Humira annual sales exceeded $1 billion ... Humira Drug Global Market Report 2024 · Adalimumab ...

3 июн. 2024 г. · The firm, which estimates that sales of Humira over its more than 20-year life have hit a staggering $187 billion, drilled down the drug's bleak ...